Natural antiglucocorticoids;Přirozené antiglukokortikoidy

Vnitrni Lekarstvi

Volumn 52, Issue 10, 2006, Pages 973-978

  Hampl, Richard ^a   Vondra, K ^a  

^a INSTITUTE OF ENDOCRINOLOGY   (Czech Republic)

Author keywords

Dehydroepiandrosterone; Endogenic antiglucocorticoids; Metabolites

Indexed keywords

ARACHIDONIC ACID; GLUCOCORTICOID; INTERLEUKIN 1; INTERLEUKIN 10; PRASTERONE; TUMOR NECROSIS FACTOR ALPHA;

ANGIOGENESIS; APOPTOSIS; CYTOKINE PRODUCTION; HORMONE ACTION; HUMAN; IMMUNE SYSTEM; MACROPHAGE MIGRATION; OXIDATIVE STRESS; REVIEW; T LYMPHOCYTE; ARTICLE; DRUG ANTAGONISM; MACROPHAGE; PHYSIOLOGY;

APOPTOSIS; DEHYDROEPIANDROSTERONE; GLUCOCORTICOIDS; HUMANS; MACROPHAGES; NEOVASCULARIZATION, PHYSIOLOGIC; OXIDATIVE STRESS;

EID: 33749626673     PISSN: 0042773X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (27)

1. Tuckermann JP, Kleiman A, McPherson KG et al. Molecular mechanisms of glucocorticoids in the control of inflammation and lymphocyte apoptosis. Crit Rev Clin Lab Sci 2005; 42: 41-104.
2. Purohit A, Reed MJ. Regulation of estrogen synthesis in postmenopausal women. Steroids 2002; 67: 979-983.
3. Chikanza IC. Mechanism of corticosteroid resistance in rheumatoid arthritis: a putative route for the corticosteroid receptor beta isoform. Ann N Y Acad Sci 2002; 966: 39-48.
4. Taguchi T, Takao T, Iwasaki M et al. Suppressive effects of dehydroepiandrosterone and the nuclear factor-kappa B inhibitor parthenolide on corticotroph tumor cell growth and function in vitro and in vivo. J Endocrinol 2006; 188: 321-331.
5. Distelhorst CW. Recent insights into the mechanism of glucocorticoid-induced apoptosis. Cell Death and Differentiation 2002; 9: 6-19.
6. Wang D, Muller N, McPherson KG et al. Glucocorticoid engage different signal transduction pathways to iduce apoptosis in thymocytes and mature T cells. J Immunol 2006; 176: 1695-1702.
7. Kalimi M, Shafagoj Y, Loria R et al. Anti-glucocorticoid effects of dehydroepiandrosterone (DHEA). Molec Cell Biochem 1994; 131: 99-104.
8. Charalampopoulos I, Alexaki VI, Lazaridis I et al. G protein-associated, specific membrane binding sites mediate the neuroprotective effect of dehydroepiandrosterone. FASEB J 2006; 20: 577-579.
9. Liang J, Yao G, Yang L et al. Dehydroepiandrosterone induces apoptosis of thymocyte through Fas/Fas-L pathway. Int Immunopharmacol 2004; 4: 1467-1475.
10. Jiang Y, Miyazaki T, Honda A et al. Apoptosis and inhibition of the phosphatidylinositol 3-kinase/Akt signaling pathway in the anti-proliferative actions of dehydroepiandrosterone. J Gastroenterol 2005; 40: 490-497.
11. Morfin R, Courchay G. Pregnenolone and dehydroepiandrosterone as precursors of native 7-hydroxylated metabolites which increase the immune response in mice. J Steroid Biochem Mol Biol 1994; 50: 91-100.
12. Lafaye P, Chmielewski V, Nato F et al. The 7α-hydroxysteroids produced in human tonsils enhance the immune response to tetanus toxoid and Bordetella pertusis antigens. Biochem Biophys Acta 1999; 1472: 222-231.
13. Chmielewski V, Drupt F, Morfin R. Dexamethasone induced apoptosis of mouse thymocytes: prevention by native 7α-hydroxysteroids. Immunol Cell Biol 2000; 78: 238-246.
14. Small GR, Hadoke PW, Sharif I et al. Preventing local regeneration of glucocorticoids by 11beta-hydroxysteroid dehydrogenase type 1 enhances angiogenesis. Proc Natl Acad Sci (USA) 2001; 102: 12165-12170.
15. Robinzon B, Michael KK, Ripp SL et al. Glucocorticoids inhibit interconversion of 7-hydroxy and 7-oxo metabolites of dehydroepiandrosterone: a role for 11β-hydroxysteroid dehydrogenases? Arch Biochem Biophys 2001; 389: 278-287
16. Hampl R, Lapčík O, Hill M et al. 7- Hydroxydehydroepiandrosterone - a natural antiglucocorticoid and a candidate for steroid replacement therapy. Physiol Res 2000; 49(Suppl 1): S107-S112.
17. Hampl R, Stárka L, Janský L. Steroids and thermogenesis (minireview). Physiol Res 2006; 55: 123-131.
18. Baus E, Andris F, Dewit J et al. Dexamethasone inhibits invasion of murine T cells through cultured fibroblastic monolayers. Int Immunopharmacol 2001; 1: 785-793.
19. Donn RP, Ray DW. Macrophage migration inhibitory factor: mollecular, cellular and genetic aspects of a key endocrine molecule. J Endocrinol 2004; 182: 1-9.
20. Rahman I. Oxidative stress and gene transcription in asthma and chronic obstructive pilmonay disease: antioxidant therapeutic targets. Curr Drug Targets Inflamm Allergy 2002; 1: 292-315.
21. Adcock IM, Caramori G, Ito K. New insights into the molecular mechanism of corticoids action. Curr Drug Targets 2006; 7: 649-660.
22. Ozmen I. Evaluation of effect of some corticosteroids on glucose-6-phosphate dehydrogenase and comparative study of antioxidant enzyme activities. J Enzyme Inhib Med Chem 2005; 20: 19-24.
23. Schwartz AG, Paschko LL. Dehydroepiandrosterone, glucose-6-phosphate dehydrogenase, and longevity. Ageing Res Rev 2004; 3: 171-187.
24. Bhaskar L, Ramakrishna BS, Balasubramanian KA. Colonic mucosal anti-oxidant enzymes and lipid peroxide levels in normal subjects and patients with ulcerative colitis. J Gastroenterol Hepatol 1995; 10: 140-143.
25. Tuzun A, Erdil A, Inal V et al. Oxidative stress and antioxidant capacity in patients with inflammatory bowel disease. Clin Biochem 2002; 35: 569-572.
26. Pélissier MA, Muller C, Hill M et al. Protection against dextran sodium sulfate-induced colitis by dehydroepiandrosterone and 7α-hydroxy-dehydroepiandrosterone in the rat. Steroids 2006; 71: 240-248.
27. Saitoh H, Hirato K, Tahara R et al. Enhancement of human phospholipase A2 activity by steroid-sulphate derived from the foeto-placental unit. Acta Endocrinol (Copenh) 1984; 107: 420-424.